Can a smartwatch help cancer patients during chemo and radiation?

NCT ID NCT05937659

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study will test whether cancer patients receiving chemotherapy and radiation therapy can use wearable health devices, like fitness trackers, to monitor their heart rate and activity levels. Twenty adults will wear the device during treatment and for four weeks after, uploading data at clinic visits. The goal is to see if this is practical in a busy clinic and if the data helps doctors provide better supportive care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
wearable health technology device
What this could lead to
If successful, this could show that wearable devices help doctors spot early signs of health decline in cancer patients during treatment, leading to better supportive care.
What could go wrong
This is a very small, early feasibility study with only 20 people. It focuses on whether patients can use the technology, not on improving outcomes. The results may not apply to all cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Novant Health Cancer Institute Radiation Oncology

    Wilmington, North Carolina, 28401, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.